microRNAs in Endometrial Cancer
- Research Opportunity
- Masters by Research, Honours, Master of Biomedical Science
- Number of Honour Places Available
- Number of Master Places Available
- Obstetrics and Gynaecology
- Royal Women’s Hospital
|Dr Ellen Menkhorstfirstname.lastname@example.org||83453780||Personal web page|
|Professor Eva Dimitriadisemail@example.com||Personal web page|
Summary Endometrial cancer is the most common gynaecological cancer in Australia. The prognosis for late stage or metastatic endometrial cancer is poor: new treatments for endometrial cancer are
Endometrial cancer is the most common gynaecological cancer in Australia and its frequency is increasing in younger women of reproductive age, largely thought to be due to increasing rates of societal obesity. The prognosis for early stage endometrial cancer is quite good, however, the prognosis for late stage or metastatic disease is poor. There are currently no effective diagnostic tests and current treatments such as hysterectomy are not suitable for younger, reproductive age women who are desirous of children. New diagnostics and therapies for endometrial cancer are urgently required. This project will investigate microRNAs in endometrial cancer and determine their diagnosticprognostic value as well as identify future therapeutic targets.
Faculty Research Themes
School Research Themes
Masters by Research, Honours, Master of Biomedical Science
Students who are interested in joining this project will need to consider their elegibility as well as other requirements before contacting the supervisor of this research
For further information about this research, please contact a supervisor.
Research NodeRoyal Women’s Hospital
MDHS Research library
Explore by researcher, school, project or topic.